CY1554A - 4-phenyl-dihydropyridine carboxylic acid derivatives - Google Patents
4-phenyl-dihydropyridine carboxylic acid derivativesInfo
- Publication number
- CY1554A CY1554A CY1554A CY155491A CY1554A CY 1554 A CY1554 A CY 1554A CY 1554 A CY1554 A CY 1554A CY 155491 A CY155491 A CY 155491A CY 1554 A CY1554 A CY 1554A
- Authority
- CY
- Cyprus
- Prior art keywords
- phenyl
- carboxylic acid
- acid derivatives
- dihydropyridine carboxylic
- dihydropyridine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT21958/85A IT1201455B (it) | 1985-08-21 | 1985-08-21 | Derivati piridinici sostituiti |
IT19480/86A IT1204458B (it) | 1986-02-20 | 1986-02-20 | Derivati eterociclici |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1554A true CY1554A (en) | 1991-03-22 |
Family
ID=26327180
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY1554A CY1554A (en) | 1985-08-21 | 1991-03-22 | 4-phenyl-dihydropyridine carboxylic acid derivatives |
Country Status (18)
Country | Link |
---|---|
US (1) | US5162345A (ko) |
JP (1) | JPH0696552B2 (ko) |
AT (1) | AT394043B (ko) |
AU (1) | AU588352B2 (ko) |
BE (1) | BE905297A (ko) |
CA (1) | CA1337295C (ko) |
CH (1) | CH669788A5 (ko) |
CY (1) | CY1554A (ko) |
DE (1) | DE3628215C2 (ko) |
DK (1) | DK397686A (ko) |
ES (1) | ES2001104A6 (ko) |
FR (1) | FR2586417B1 (ko) |
GB (1) | GB2181127B (ko) |
IE (1) | IE59632B1 (ko) |
NL (1) | NL192385C (ko) |
NZ (1) | NZ217282A (ko) |
SE (1) | SE465367B (ko) |
SG (1) | SG40890G (ko) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9405833D0 (en) * | 1994-03-24 | 1994-05-11 | Pfizer Ltd | Separation of the enantiomers of amlodipine |
AU761467B2 (en) * | 1998-06-09 | 2003-06-05 | Ajinomoto Co., Inc. | Novel enzyme-treated protein-containing food, and methods for producing the same |
FR2892412B1 (fr) * | 2005-10-26 | 2008-05-16 | Galderma Res & Dev | Composes biaromatiques modulateurs des ppars |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3455945A (en) * | 1967-06-07 | 1969-07-15 | Smithkline Corp | 4-(carboxy (and carbo-lower alkoxy)phenyl)-1,4-dihydropyridines |
DE2228363A1 (de) * | 1972-06-10 | 1974-01-03 | Bayer Ag | 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
GB1409865A (en) * | 1973-02-13 | 1975-10-15 | Science Union & Cie | Dihydropyridines derivatives their preparation and pharmaceu tical compositions containing them |
DE2740080A1 (de) * | 1977-09-06 | 1979-03-15 | Bayer Ag | 2-alkylenaminodihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
DE2753946A1 (de) * | 1977-12-03 | 1979-06-13 | Bayer Ag | 1-n-aryl-1,4-dihydropyridine und ihre verwendung als arzneimittel |
US4307103A (en) * | 1978-09-08 | 1981-12-22 | Fujisawa Pharmaceutical Co., Ltd. | Dihydropyridine derivative, processes for preparation thereof and pharmaceutical composition comprising the same |
CS228917B2 (en) * | 1981-03-14 | 1984-05-14 | Pfizer | Method of preparing substituted derivatives of 1,4-dihydropyridine |
DE3207982A1 (de) * | 1982-03-05 | 1983-09-08 | Bayer Ag, 5090 Leverkusen | Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln |
AU561213B2 (en) * | 1983-06-02 | 1987-04-30 | Teijin Limited | 1, 4-dihydropyridine derivative |
NZ212895A (en) * | 1984-08-22 | 1988-07-28 | Glaxo Spa | 1,4-dihydropyridine derivatives and pharmaceutical compositions |
IT1204462B (it) * | 1986-02-20 | 1989-03-01 | Glaxo Spa | Derivati eterociclici |
DE3607821A1 (de) * | 1986-03-08 | 1987-09-10 | Bayer Ag | Aminoester-dihydropyridine, verfahren zur herstellung und ihre verwendung |
US4814455A (en) * | 1986-04-16 | 1989-03-21 | Bristol-Myers Company | Dihydro-3,5-dicarboxylates |
-
1986
- 1986-08-20 CH CH3340/86A patent/CH669788A5/de not_active IP Right Cessation
- 1986-08-20 FR FR868611893A patent/FR2586417B1/fr not_active Expired - Lifetime
- 1986-08-20 GB GB8620217A patent/GB2181127B/en not_active Expired
- 1986-08-20 CA CA000516391A patent/CA1337295C/en not_active Expired - Fee Related
- 1986-08-20 AT AT0223986A patent/AT394043B/de not_active IP Right Cessation
- 1986-08-20 IE IE222786A patent/IE59632B1/en not_active IP Right Cessation
- 1986-08-20 SE SE8603517A patent/SE465367B/sv not_active IP Right Cessation
- 1986-08-20 NZ NZ217282A patent/NZ217282A/xx unknown
- 1986-08-20 ES ES8601217A patent/ES2001104A6/es not_active Expired
- 1986-08-20 BE BE0/217060A patent/BE905297A/fr not_active IP Right Cessation
- 1986-08-20 JP JP61192990A patent/JPH0696552B2/ja not_active Expired - Lifetime
- 1986-08-20 NL NL8602117A patent/NL192385C/nl not_active IP Right Cessation
- 1986-08-20 DK DK397686A patent/DK397686A/da not_active Application Discontinuation
- 1986-08-20 AU AU61668/86A patent/AU588352B2/en not_active Ceased
- 1986-08-20 DE DE3628215A patent/DE3628215C2/de not_active Expired - Fee Related
-
1990
- 1990-06-11 SG SG408/90A patent/SG40890G/en unknown
- 1990-08-20 US US07/673,510 patent/US5162345A/en not_active Expired - Fee Related
-
1991
- 1991-03-22 CY CY1554A patent/CY1554A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
GB2181127A (en) | 1987-04-15 |
CA1337295C (en) | 1995-10-10 |
NZ217282A (en) | 1989-01-27 |
ES2001104A6 (es) | 1988-04-16 |
NL192385C (nl) | 1997-07-04 |
BE905297A (fr) | 1987-02-20 |
FR2586417B1 (fr) | 1991-08-30 |
FR2586417A1 (fr) | 1987-02-27 |
SE8603517L (sv) | 1987-02-22 |
US5162345A (en) | 1992-11-10 |
SE465367B (sv) | 1991-09-02 |
DK397686A (da) | 1987-02-22 |
GB2181127B (en) | 1989-08-02 |
JPH0696552B2 (ja) | 1994-11-30 |
JPS6296467A (ja) | 1987-05-02 |
CH669788A5 (ko) | 1989-04-14 |
DK397686D0 (da) | 1986-08-20 |
AT394043B (de) | 1992-01-27 |
AU588352B2 (en) | 1989-09-14 |
SG40890G (en) | 1990-08-03 |
DE3628215A1 (de) | 1987-02-26 |
AU6166886A (en) | 1987-02-26 |
ATA223986A (de) | 1991-07-15 |
NL192385B (nl) | 1997-03-03 |
NL8602117A (nl) | 1987-03-16 |
SE8603517D0 (sv) | 1986-08-20 |
GB8620217D0 (en) | 1986-10-01 |
IE59632B1 (en) | 1994-03-09 |
IE862227L (en) | 1987-02-21 |
DE3628215C2 (de) | 1996-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH22790A (en) | Thiazolidine carboxylic acid derivatives | |
GB8607855D0 (en) | Carboxylic acid ester derivatives | |
GB8417314D0 (en) | Carboxylic acid derivatives | |
GB8630759D0 (en) | Carboxylic acid derivatives | |
GR861006B (en) | Vinylcyclopropancarbon acid ester | |
ZA899942B (en) | Carboxylic acid derivatives | |
GB8509086D0 (en) | Dihydronicotinic acid derivatives | |
GR3002821T3 (en) | Carboxylic acid derivatives | |
GB8604686D0 (en) | Carboxylic acids | |
GB2181127B (en) | 4-phenyl-dihydropyridine carboxylic acid derivatives | |
GB8520583D0 (en) | Azidosulphonylbenzoic acid | |
GB2177696B (en) | Ceph-3-em-4-carboxylic acid derivatives | |
GB8531873D0 (en) | Carboxylic acid derivatives | |
GB8507861D0 (en) | Carboxylic acid derivatives | |
GB8413385D0 (en) | Carboxylic acid derivatives | |
GB2174707B (en) | Octenoic acid derivatives | |
DE3664043D1 (en) | Pyridyloxyphenoxypropionic acid derivatives | |
GB8426475D0 (en) | Carboxylic acid derivatives | |
IE861892L (en) | Carboxylic acid derivatives | |
GB8607839D0 (en) | Carboxylic acid derivatives | |
GB8630760D0 (en) | Carboxylic acid derivatives | |
IE852291L (en) | 7-aryl0xynaphth-2-yloxy alkanoic acid derivatives | |
IE852065L (en) | Chroman carboxylic acid derivatives | |
IE852004L (en) | Quinolone carboxylic acid derivatives | |
IE851461L (en) | Carboxylic acid derivatives of deglucoteicoplanin |